Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 4
Submit an article Journal homepage
111
Views
22
CrossRef citations to date
0
Altmetric
Commentary

Initial experience with teriparatide in the United States

Deborah T. Gold Departments of Psychiatry and Behavioral Sciences, Sociology, and Psychology, Social and Health Sciences, Duke Aging Center, Duke University Medical Center, Durham, NC, USA
,
Barbara S. Pantos Eli Lilly and Company Indianapolis, IN, USA
,
Daniel N. Masica Eli Lilly and Company Indianapolis, IN, USA
,
Derek A. Misurski Eli Lilly and Company Indianapolis, IN, USA
&
Robert Marcus Eli Lilly and Company Indianapolis, IN, USACorrespondence[email protected]
Pages 703-708 | Accepted 23 Feb 2006, Published online: 16 Mar 2006

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Adam D Taylor & Kenneth G Saag. (2019) Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy. Core Evidence 14, pages 41-50.
Read now
Claudia Gagnon, Vivien Li & Peter R Ebeling. (2008) Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Clinical Interventions in Aging 3:4, pages 635-645.
Read now
Alan Kivitz & Oscar G Segurado. (2007) HUMIRA® Pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab. Expert Review of Medical Devices 4:2, pages 109-116.
Read now
Kristine D. Harper, John H. Krege, Robert Marcus & Bruce H. Mitlak. (2006) Comments on Initial experience with teriparatide in the United States. Current Medical Research and Opinion 22:10, pages 1927-1927.
Read now

Articles from other publishers (18)

Jean Zhang & Elaine Dennison. 2021. Osteoporosis Treatment. Osteoporosis Treatment 81 95 .
Andrea V Haas & Meryl S LeBoff. (2018) Osteoanabolic Agents for Osteoporosis. Journal of the Endocrine Society 2:8, pages 922-932.
Crossref
Ernesto Canalis. (2018) MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis. European Journal of Endocrinology 178:2, pages R33-R44.
Crossref
Robert J. Pignolo & Mona Al Mukaddam. 2018. Fractures in the Elderly. Fractures in the Elderly 285 301 .
Nirosshan Thiruchelvam, Jaskirat Randhawa, Happy Sadiek & Gaurav Kistangari. (2014) Teriparatide Induced Delayed Persistent Hypercalcemia. Case Reports in Endocrinology 2014, pages 1-3.
Crossref
Marilyn Augustine & Mara J. Horwitz. (2013) Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs as Therapies for Osteoporosis. Current Osteoporosis Reports 11:4, pages 400-406.
Crossref
Deborah T. Gold. 2013. Osteoporosis. Osteoporosis 1909 1921 .
Cristiana Capriani, Dinaz Irani & John P Bilezikian. (2012) Safety of osteoanabolic therapy: A decade of experience. Journal of Bone and Mineral Research 27:12, pages 2419-2428.
Crossref
Aaron M. Carlson, Kristen B. Thomas, Salman Kirmani & Noralane M. Lindor. (2012) Chronic tibial nonunion in a Rothmund-Thomson syndrome patient. American Journal of Medical Genetics Part A 158A:9, pages 2250-2253.
Crossref
Anne L. Schafer, Lisa Palermo, Douglas C. Bauer, John P. Bilezikian, Deborah E. Sellmeyer & Dennis M. Black. (2011) Consistency of Bone Turnover Marker and Calcium Responses to Parathyroid Hormone (1?84) Therapy in Postmenopausal Osteoporosis. Journal of Clinical Densitometry 14:1, pages 68-73.
Crossref
Robert J. Pignolo. 2011. Fractures in the Elderly. Fractures in the Elderly 309 328 .
Daniel H Solomon, Laura Rekedal & Suzanne M Cadarette. (2009) Osteoporosis treatments and adverse events. Current Opinion in Rheumatology 21:4, pages 363-368.
Crossref
Johannes Pleiner-Duxneuner, Elisabeth Zwettler, Eleftherios Paschalis, Paul Roschger, Valerie Nell-Duxneuner & Klaus Klaushofer. (2009) Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide. Calcified Tissue International 84:3, pages 159-170.
Crossref
Debra L. Barton, Aditya Bardia & Charles Loprinzi. 2009. Supportive Care in Cancer Therapy. Supportive Care in Cancer Therapy 227 248 .
Jeffrey Stroup, Michael P. Kane & Asim M. Abu-Baker. (2008) Teriparatide in the treatment of osteoporosis. American Journal of Health-System Pharmacy 65:6, pages 532-539.
Crossref
Ernesto Canalis, Andrea Giustina & John P. Bilezikian. (2007) Mechanisms of Anabolic Therapies for Osteoporosis. New England Journal of Medicine 357:9, pages 905-916.
Crossref
Trisha Greenhalgh. 2007. Primary Health Care. Primary Health Care 57 89 .
Kristine D Harper, John H Krege, Robert Marcus & Bruce H Mitlak. (2006) Osteosarcoma and Teriparatide?. Journal of Bone and Mineral Research 22:2, pages 334-334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.